title: Adjuvant Dendritic Cell Vaccination in High-Risk Uveal Melanoma.
authors.affiliation: Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands.
authors.forename: Kalijn F
authors.initials: KF
authors.lastname: Bol
authors.affiliation: Department of Ocular Oncology, Rotterdam Eye Hospital, Rotterdam, The Netherlands.
authors.forename: Thomas
authors.initials: T
authors.lastname: van den Bosch
authors.affiliation: Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
authors.forename: Gerty
authors.initials: G
authors.lastname: Schreibelt
authors.affiliation: Department of Ocular Oncology, Rotterdam Eye Hospital, Rotterdam, The Netherlands; Department of Clinical Genetics, Erasmus Medical Centre, Rotterdam, The Netherlands.
authors.forename: Hanneke W
authors.initials: HW
authors.lastname: Mensink
authors.affiliation: Department of Ophthalmology, Radboud University Medical Centre, Nijmegen, The Netherlands.
authors.forename: Jan E E
authors.initials: JE
authors.lastname: Keunen
authors.affiliation: Department of Ophthalmology, Erasmus Medical Centre, Rotterdam, The Netherlands.
authors.forename: Emine
authors.initials: E
authors.lastname: Kiliç
authors.affiliation: Department of Ophthalmology, University Medical Center Groningen, Groningen, The Netherlands.
authors.forename: Wouter J
authors.initials: WJ
authors.lastname: Japing
authors.affiliation: Department of Internal Medicine, Sint Franciscus Hospital, Rotterdam, The Netherlands.
authors.forename: Kaspar W
authors.initials: KW
authors.lastname: Geul
authors.affiliation: Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands.
authors.forename: Harm
authors.initials: H
authors.lastname: Westdorp
authors.affiliation: Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands.
authors.forename: Steve
authors.initials: S
authors.lastname: Boudewijns
authors.affiliation: Department of Hematology, Radboud University Medical Centre, Nijmegen, The Netherlands.
authors.forename: Sandra A J
authors.initials: SA
authors.lastname: Croockewit
authors.affiliation: Department of Dermatology, Radboud University Medical Centre, Nijmegen, The Netherlands.
authors.forename: Michelle M
authors.initials: MM
authors.lastname: van Rossum
authors.affiliation: Department of Pharmacy, Radboud University Medical Centre, Nijmegen, The Netherlands.
authors.forename: Anna L
authors.initials: AL
authors.lastname: de Goede
authors.affiliation: Department of Ophthalmology, Erasmus Medical Centre, Rotterdam, The Netherlands.
authors.forename: Nicole C
authors.initials: NC
authors.lastname: Naus
authors.affiliation: Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands; Department of Medical Oncology, The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London, United Kingdom.
authors.forename: Winette T A
authors.initials: WT
authors.lastname: van der Graaf
authors.affiliation: Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands.
authors.forename: Winald R
authors.initials: WR
authors.lastname: Gerritsen
authors.affiliation: Department of Clinical Genetics, Erasmus Medical Centre, Rotterdam, The Netherlands.
authors.forename: Annelies
authors.initials: A
authors.lastname: de Klein
authors.affiliation: Department of Medical Oncology, Academic Medical Center, Amsterdam, The Netherlands.
authors.forename: Cornelis J A
authors.initials: CJ
authors.lastname: Punt
authors.affiliation: Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
authors.forename: Carl G
authors.initials: CG
authors.lastname: Figdor
authors.affiliation: Department of Ophthalmology, Moorfields Eye Hospital and St. Bartholomew's Hospital, London, United Kingdom.
authors.forename: Victoria M
authors.initials: VM
authors.lastname: Cohen
authors.affiliation: Department of Ocular Oncology, Rotterdam Eye Hospital, Rotterdam, The Netherlands; Department of Ophthalmology, Erasmus Medical Centre, Rotterdam, The Netherlands.
authors.forename: Dion
authors.initials: D
authors.lastname: Paridaens
authors.affiliation: Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands. Electronic address: Jolanda.deVries@radboudumc.nl.
authors.forename: I Jolanda M
authors.initials: IJ
authors.lastname: de Vries
mesh_terms: D000328:Adult; D000368:Aged; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D019496:Cancer Vaccines / Q000008:administration & dosage*; D003713:Dendritic Cells / Q000276:immunology*; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D008297:Male; D008545:Melanoma / Q000276:immunology / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D008875:Middle Aged; D014442:Monophenol Monooxygenase / Q000276:immunology; D015996:Survival Rate; D014604:Uveal Neoplasms / Q000276:immunology / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D014611:Vaccination; D058951:gp100 Melanoma Antigen / Q000276:immunology; D000098943:Uveal Melanoma
chemical_list: D019496:Cancer Vaccines; D058951:gp100 Melanoma Antigen; D014442:Monophenol Monooxygenase